LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

Accueil・Liste d'Actions・ADMA Biologics Inc

ADMA Biologics Inc

Fermé

Secteur Soins de santé

15.66 0.45

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

15.33

Max

15.78

Chiffres clés
By Trading Economics
Revenu	35M 18M
Ventes	8M 82M
BPA	0.08
Marge bénéficiaire	21.748
Employés	624
EBITDA	7.9M 24M

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+21.64 upside

Dividendes
By Dow Jones
Prochains Résultats	6 nov. 2024

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-671M 3.8B
Ouverture précédente	15.21
Clôture précédente	15.66

Sentiment de l'Actualité

By Acuity

77%

23%

367 / 390 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

N/A / 16.44 Support & Résistance

ADMA Biologics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 oct. 2024, 21:55 UTC

Principaux Mouvements du Marché

McDonald's Shares Fall After CDC Says E. Coli Outbreak Linked to Quarter Pounders -- Update

22 oct. 2024, 21:48 UTC

Actualités

CDC Says E. Coli Outbreak Linked to McDonald's Quarter Pounders -- Update

22 oct. 2024, 21:37 UTC

Principaux Mouvements du Marché

DBV Technologies Rally 47% Following Positive Updates for Peanut Allergy Patch

22 oct. 2024, 21:30 UTC

Principaux Mouvements du Marché

McDonald's Shares Fall After CDC Says E. Coli Outbreak Linked to Quarter Pounders

22 oct. 2024, 21:12 UTC

Actualités

CDC Says E. Coli Outbreak Linked to McDonald's Quarter Pounders

22 oct. 2024, 20:52 UTC

Actualités

Résultats

Starbucks Suspends Guidance After Sales Slump Persists

22 oct. 2024, 20:49 UTC

Actualités

Résultats

Canadian National Railway Posts Higher Revenue, Lower Profit in 3Q

22 oct. 2024, 20:28 UTC

Résultats

Texas Instruments Posts Lower 3Q Revenue

22 oct. 2024, 23:24 UTC

Actualités

Résultats

Starbucks Suspends Guidance as Sales Slump Persists -- 2nd Update

22 oct. 2024, 22:54 UTC

Market Talk

Global Equities Roundup: Market Talk

22 oct. 2024, 22:53 UTC

Market Talk

CSL's R&D Update Seen as Neutral Overall -- Market Talk

22 oct. 2024, 22:46 UTC

Actualités

Meta Bans Accounts That Track Celebrity Jet Travel, Including for Zuckerberg -- WSJ

22 oct. 2024, 22:45 UTC

Actualités

McDonald's Quarter Pounders Linked to Deadly E. Coli Outbreak -- 3rd Update

22 oct. 2024, 21:58 UTC

Actualités

Résultats

Starbucks Suspends Guidance as Sales Slump Persists -- Update

22 oct. 2024, 21:53 UTC

Actualités

McDonald's Quarter Pounders Linked to Deadly E. Coli Outbreak -- 2nd Update

22 oct. 2024, 21:19 UTC

Actualités

Texas Instruments' Guidance Falls Short. The Stock Is Rising Anyway. -- Barrons.com

22 oct. 2024, 21:14 UTC

Actualités

Résultats

3M Produces Beat-and-Raise Earnings. The Stock Dropped. -- Barrons.com

22 oct. 2024, 21:05 UTC

Actualités

McDonald's Quarter Pounders Linked to Deadly E. Coli Outbreak -- Update

22 oct. 2024, 20:55 UTC

Résultats

Philip Morris International Stock Surges to Record -- WSJ

22 oct. 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

22 oct. 2024, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

22 oct. 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22 oct. 2024, 20:48 UTC

Actualités

McDonald's Quarter Pounders Linked to Deadly E. Coli Outbreak -- WSJ

22 oct. 2024, 20:45 UTC

Actualités

Treasury Yields Rise, S&P 500 Edges Lower After Earnings Flurry -- WSJ

22 oct. 2024, 20:45 UTC

Résultats

GE Aerospace Stock Skids Amid Commercial-Engine Concerns -- WSJ

22 oct. 2024, 20:34 UTC

Actualités

Résultats

Starbucks Stock Drops After Company Misses Earnings, Suspends Guidance -- Barrons.com

22 oct. 2024, 20:22 UTC

Résultats

Nabors: Expects 4Q U.S. Drilling Lower 48 Avg Rig Count of Approximately 68 Rigs >NBR

22 oct. 2024, 20:22 UTC

Résultats

Nabors: Expects Full-Yr Cap Expenditures of Approximately $600M, With $230M for the SANAD Newbuilds >NBR

22 oct. 2024, 20:22 UTC

Résultats

Nabors: Expects 4Q International Avg Rig Count of Approximately 84 Rigs >NBR

22 oct. 2024, 20:22 UTC

Résultats

Nabors: Expects 4Q Cap Expenditures of $230M, With $105M for the Newbuilds in Saudi Arabia >NBR

Comparaison

Variation de prix

ADMA Biologics Inc prévision

Objectif de Prix

By TipRanks

21.64% hausse

Prévisions sur 12 Mois

Moyen 19 USD 21.64%

Haut 20 USD

Bas 18 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

3 ratings

Achat

Maintien

Vente

Basé sur 3 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

N/A / 16.44Support & Résistance

Recent bearish events outweigh bullish events.

All events are bearish.

There is one bullish event.

Sentiment

By Acuity

367 / 390Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos ADMA Biologics Inc

ADMA Biologics, Inc. is a biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments include ADMA BioManufacturing and Plasma Collection Centers. The Company’s ADMA BioManufacturing segment reflects its immune globulin manufacturing and development operations in Florida. The Plasma Collection Centers segment consists of approximately three plasma collection facilities. Its products include BIVIGAM, ASCENIV and Nabi-HB. Its product candidates are intended to be used by physician specialists focused on caring for immune-compromised patients at risk of contracting infectious diseases. Its targeted patient populations are immune-compromised individuals suffering from an underlying immune deficiency disorder or may be immune-suppressed for medical reasons.